Carregant...
Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma
BACKGROUND: Mesenchymal chondrosarcoma is an exceedingly rare malignancy, accounting for around 5% of all patients with chondrosarcoma. It is a translocation-related sarcoma that tends to have both local and distant recurrences. Surgery is the mainstay of treatment in localised cases however treatme...
Guardat en:
| Publicat a: | Clin Sarcoma Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7453529/ https://ncbi.nlm.nih.gov/pubmed/32864096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-020-00138-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|